HEADER TRANSCRIPTION, RNA BINDING PROTEIN/RNA 11-JAN-08 3BX2 TITLE PUF4 RNA BINDING DOMAIN BOUND TO HO ENDONUCLEASE RNA 3' UTR TITLE 2 RECOGNITION SEQUENCE COMPND MOL_ID: 1; COMPND 2 MOLECULE: HO ENDONUCLEASE 3' UTR BINDING SEQUENCE; COMPND 3 CHAIN: C, D; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: PROTEIN PUF4; COMPND 7 CHAIN: A, B; COMPND 8 FRAGMENT: SINGLE STRANDED RNA BINDING DOMIN; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 MOL_ID: 2; SOURCE 4 ORGANISM_SCIENTIFIC: SACCHAROMYCES CEREVISIAE; SOURCE 5 ORGANISM_COMMON: BAKER'S YEAST; SOURCE 6 ORGANISM_TAXID: 4932; SOURCE 7 GENE: PUF4; SOURCE 8 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 9 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID KEYWDS PUF4, PUMILIO, RNA BINDING, HO ENDONUCLEASE, TRANSCRIPTION, RNA KEYWDS 2 BINDING PROTEIN-RNA COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR M.T.MILLER,J.J.HIGGIN,T.M.T.HALL REVDAT 4 21-FEB-24 3BX2 1 REMARK REVDAT 3 24-FEB-09 3BX2 1 VERSN REVDAT 2 22-JUL-08 3BX2 1 JRNL REMARK REVDAT 1 11-MAR-08 3BX2 0 JRNL AUTH M.T.MILLER,J.J.HIGGIN,T.M.T.HALL JRNL TITL BASIS OF ALTERED RNA-BINDING SPECIFICITY BY PUF PROTEINS JRNL TITL 2 REVEALED BY CRYSTAL STRUCTURES OF YEAST PUF4P JRNL REF NAT.STRUCT.MOL.BIOL. V. 15 397 2008 JRNL REFN ISSN 1545-9993 JRNL PMID 18327269 JRNL DOI 10.1038/NSMB.1390 REMARK 2 REMARK 2 RESOLUTION. 2.84 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.84 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 14.90 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 2.000 REMARK 3 COMPLETENESS FOR RANGE (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 32060 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.240 REMARK 3 FREE R VALUE : 0.280 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 645 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 2.8600 - 2.8400 0.74 0 0 0.3400 0.0000 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : NULL REMARK 3 SHRINKAGE RADIUS : NULL REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : NULL REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : NULL REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.010 NULL REMARK 3 ANGLE : 1.239 NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3BX2 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 07-FEB-08. REMARK 100 THE DEPOSITION ID IS D_1000046063. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-JUL-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 HF REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : VARIMAX REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU SATURN 92 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 32060 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.840 REMARK 200 RESOLUTION RANGE LOW (A) : 14.900 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.2 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.84 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.00 REMARK 200 COMPLETENESS FOR SHELL (%) : 94.2 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: SOLVE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 71.83 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 4.37 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.2 M AMMONIUM SULFATE, 100 MM TRIS PH REMARK 280 8.0, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 32.93000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 79.42550 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 68.09000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 79.42550 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 32.93000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 68.09000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: D, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 554 REMARK 465 ARG A 555 REMARK 465 PHE A 556 REMARK 465 ALA A 557 REMARK 465 ASP A 558 REMARK 465 ALA A 559 REMARK 465 SER A 888 REMARK 465 SER B 554 REMARK 465 ARG B 555 REMARK 465 PHE B 556 REMARK 465 ALA B 557 REMARK 465 ASP B 558 REMARK 465 ALA B 559 REMARK 465 VAL B 560 REMARK 465 LEU B 561 REMARK 465 HIS B 885 REMARK 465 LEU B 886 REMARK 465 ASP B 887 REMARK 465 SER B 888 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ILE A 565 154.78 -41.50 REMARK 500 ALA A 595 -75.49 -71.20 REMARK 500 PHE A 597 -70.01 -47.22 REMARK 500 SER A 712 52.67 -101.53 REMARK 500 LEU A 748 45.83 -140.88 REMARK 500 ASP A 776 -73.77 -127.96 REMARK 500 ASN A 821 -74.74 -56.04 REMARK 500 ASN A 852 117.92 -163.83 REMARK 500 TYR B 564 -17.32 82.71 REMARK 500 SER B 567 -173.47 63.97 REMARK 500 ILE B 568 -54.92 -132.24 REMARK 500 ALA B 595 -75.95 -70.40 REMARK 500 PHE B 597 -73.29 -49.58 REMARK 500 SER B 712 52.89 -104.87 REMARK 500 LEU B 748 44.09 -141.99 REMARK 500 ASP B 776 -76.19 -127.53 REMARK 500 ASN B 821 -76.55 -54.24 REMARK 500 ASN B 852 117.95 -163.09 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 LEU B 588 GLY B 589 -138.06 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 951 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 952 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 954 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 955 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 956 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 957 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 958 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1M6W RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE PUMILIO-HOMOLOGY DOMAIN FROM HUMAN REMARK 900 PUMILIO1 IN COMPLEX WITH NRE1-19 RNA REMARK 900 RELATED ID: 1M8X RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE PUMILIO-HOMOLOGY DOMAIN FROM HUMAN REMARK 900 PUMILIO1 IN COMPLEX WITH NRE1-14 RNA REMARK 900 RELATED ID: 1M8Y RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE PUMILIO-HOMOLOGY DOMAIN FROM HUMAN REMARK 900 PUMILIO1 IN COMPLEX WITH NRE2-10 RNA REMARK 900 RELATED ID: 1M8Z RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF A PUMILIO-HOMOLOGY DOMAIN REMARK 900 RELATED ID: 1IB2 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF A PUMILIO-HOMOLOGY DOMAIN REMARK 900 RELATED ID: 3BWT RELATED DB: PDB REMARK 900 RELATED ID: 3BX3 RELATED DB: PDB DBREF 3BX2 A 554 888 UNP P25339 PUF4_YEAST 554 888 DBREF 3BX2 B 554 888 UNP P25339 PUF4_YEAST 554 888 DBREF 3BX2 C 1 9 PDB 3BX2 3BX2 1 9 DBREF 3BX2 D 1 9 PDB 3BX2 3BX2 1 9 SEQRES 1 C 9 U G U A U A U U A SEQRES 1 D 9 U G U A U A U U A SEQRES 1 A 335 SER ARG PHE ALA ASP ALA VAL LEU ASP GLN TYR ILE GLY SEQRES 2 A 335 SER ILE HIS SER LEU CYS LYS ASP GLN HIS GLY CYS ARG SEQRES 3 A 335 PHE LEU GLN LYS GLN LEU ASP ILE LEU GLY SER LYS ALA SEQRES 4 A 335 ALA ASP ALA ILE PHE GLU GLU THR LYS ASP TYR THR VAL SEQRES 5 A 335 GLU LEU MET THR ASP SER PHE GLY ASN TYR LEU ILE GLN SEQRES 6 A 335 LYS LEU LEU GLU GLU VAL THR THR GLU GLN ARG ILE VAL SEQRES 7 A 335 LEU THR LYS ILE SER SER PRO HIS PHE VAL GLU ILE SER SEQRES 8 A 335 LEU ASN PRO HIS GLY THR ARG ALA LEU GLN LYS LEU ILE SEQRES 9 A 335 GLU CYS ILE LYS THR ASP GLU GLU ALA GLN ILE VAL VAL SEQRES 10 A 335 ASP SER LEU ARG PRO TYR THR VAL GLN LEU SER LYS ASP SEQRES 11 A 335 LEU ASN GLY ASN HIS VAL ILE GLN LYS CYS LEU GLN ARG SEQRES 12 A 335 LEU LYS PRO GLU ASN PHE GLN PHE ILE PHE ASP ALA ILE SEQRES 13 A 335 SER ASP SER CYS ILE ASP ILE ALA THR HIS ARG HIS GLY SEQRES 14 A 335 CYS CYS VAL LEU GLN ARG CYS LEU ASP HIS GLY THR THR SEQRES 15 A 335 GLU GLN CYS ASP ASN LEU CYS ASP LYS LEU LEU ALA LEU SEQRES 16 A 335 VAL ASP LYS LEU THR LEU ASP PRO PHE GLY ASN TYR VAL SEQRES 17 A 335 VAL GLN TYR ILE ILE THR LYS GLU ALA GLU LYS ASN LYS SEQRES 18 A 335 TYR ASP TYR THR HIS LYS ILE VAL HIS LEU LEU LYS PRO SEQRES 19 A 335 ARG ALA ILE GLU LEU SER ILE HIS LYS PHE GLY SER ASN SEQRES 20 A 335 VAL ILE GLU LYS ILE LEU LYS THR ALA ILE VAL SER GLU SEQRES 21 A 335 PRO MET ILE LEU GLU ILE LEU ASN ASN GLY GLY GLU THR SEQRES 22 A 335 GLY ILE GLN SER LEU LEU ASN ASP SER TYR GLY ASN TYR SEQRES 23 A 335 VAL LEU GLN THR ALA LEU ASP ILE SER HIS LYS GLN ASN SEQRES 24 A 335 ASP TYR LEU TYR LYS ARG LEU SER GLU ILE VAL ALA PRO SEQRES 25 A 335 LEU LEU VAL GLY PRO ILE ARG ASN THR PRO HIS GLY LYS SEQRES 26 A 335 ARG ILE ILE GLY MET LEU HIS LEU ASP SER SEQRES 1 B 335 SER ARG PHE ALA ASP ALA VAL LEU ASP GLN TYR ILE GLY SEQRES 2 B 335 SER ILE HIS SER LEU CYS LYS ASP GLN HIS GLY CYS ARG SEQRES 3 B 335 PHE LEU GLN LYS GLN LEU ASP ILE LEU GLY SER LYS ALA SEQRES 4 B 335 ALA ASP ALA ILE PHE GLU GLU THR LYS ASP TYR THR VAL SEQRES 5 B 335 GLU LEU MET THR ASP SER PHE GLY ASN TYR LEU ILE GLN SEQRES 6 B 335 LYS LEU LEU GLU GLU VAL THR THR GLU GLN ARG ILE VAL SEQRES 7 B 335 LEU THR LYS ILE SER SER PRO HIS PHE VAL GLU ILE SER SEQRES 8 B 335 LEU ASN PRO HIS GLY THR ARG ALA LEU GLN LYS LEU ILE SEQRES 9 B 335 GLU CYS ILE LYS THR ASP GLU GLU ALA GLN ILE VAL VAL SEQRES 10 B 335 ASP SER LEU ARG PRO TYR THR VAL GLN LEU SER LYS ASP SEQRES 11 B 335 LEU ASN GLY ASN HIS VAL ILE GLN LYS CYS LEU GLN ARG SEQRES 12 B 335 LEU LYS PRO GLU ASN PHE GLN PHE ILE PHE ASP ALA ILE SEQRES 13 B 335 SER ASP SER CYS ILE ASP ILE ALA THR HIS ARG HIS GLY SEQRES 14 B 335 CYS CYS VAL LEU GLN ARG CYS LEU ASP HIS GLY THR THR SEQRES 15 B 335 GLU GLN CYS ASP ASN LEU CYS ASP LYS LEU LEU ALA LEU SEQRES 16 B 335 VAL ASP LYS LEU THR LEU ASP PRO PHE GLY ASN TYR VAL SEQRES 17 B 335 VAL GLN TYR ILE ILE THR LYS GLU ALA GLU LYS ASN LYS SEQRES 18 B 335 TYR ASP TYR THR HIS LYS ILE VAL HIS LEU LEU LYS PRO SEQRES 19 B 335 ARG ALA ILE GLU LEU SER ILE HIS LYS PHE GLY SER ASN SEQRES 20 B 335 VAL ILE GLU LYS ILE LEU LYS THR ALA ILE VAL SER GLU SEQRES 21 B 335 PRO MET ILE LEU GLU ILE LEU ASN ASN GLY GLY GLU THR SEQRES 22 B 335 GLY ILE GLN SER LEU LEU ASN ASP SER TYR GLY ASN TYR SEQRES 23 B 335 VAL LEU GLN THR ALA LEU ASP ILE SER HIS LYS GLN ASN SEQRES 24 B 335 ASP TYR LEU TYR LYS ARG LEU SER GLU ILE VAL ALA PRO SEQRES 25 B 335 LEU LEU VAL GLY PRO ILE ARG ASN THR PRO HIS GLY LYS SEQRES 26 B 335 ARG ILE ILE GLY MET LEU HIS LEU ASP SER HET SO4 A 951 5 HET SO4 A 956 5 HET SO4 A 957 5 HET SO4 A 958 5 HET NA B 901 1 HET NA B 902 1 HET SO4 B 952 5 HET SO4 B 953 5 HET SO4 B 954 5 HET SO4 B 955 5 HETNAM SO4 SULFATE ION HETNAM NA SODIUM ION FORMUL 5 SO4 8(O4 S 2-) FORMUL 9 NA 2(NA 1+) FORMUL 15 HOH *58(H2 O) HELIX 1 1 ILE A 568 LYS A 573 5 6 HELIX 2 2 ASP A 574 GLY A 589 1 16 HELIX 3 3 SER A 590 LYS A 601 1 12 HELIX 4 4 TYR A 603 THR A 609 1 7 HELIX 5 5 PHE A 612 VAL A 624 1 13 HELIX 6 6 THR A 625 SER A 637 1 13 HELIX 7 7 HIS A 639 LEU A 645 1 7 HELIX 8 8 HIS A 648 ILE A 660 1 13 HELIX 9 9 THR A 662 ARG A 674 1 13 HELIX 10 10 TYR A 676 LYS A 682 1 7 HELIX 11 11 GLY A 686 LEU A 697 1 12 HELIX 12 12 LYS A 698 SER A 712 1 15 HELIX 13 13 SER A 712 THR A 718 1 7 HELIX 14 14 HIS A 721 GLY A 733 1 13 HELIX 15 15 THR A 734 ALA A 747 1 14 HELIX 16 16 LEU A 748 LEU A 754 1 7 HELIX 17 17 PHE A 757 ASN A 773 1 17 HELIX 18 18 ASP A 776 LYS A 786 1 11 HELIX 19 19 ARG A 788 ILE A 794 1 7 HELIX 20 20 PHE A 797 LYS A 807 1 11 HELIX 21 21 THR A 808 ASP A 834 1 27 HELIX 22 22 TYR A 836 ASN A 852 1 17 HELIX 23 23 ASN A 852 LEU A 867 1 16 HELIX 24 24 GLY A 869 ASN A 873 5 5 HELIX 25 25 THR A 874 GLY A 882 1 9 HELIX 26 26 HIS B 569 LYS B 573 5 5 HELIX 27 27 ASP B 574 LEU B 588 1 15 HELIX 28 28 SER B 590 LYS B 601 1 12 HELIX 29 29 TYR B 603 THR B 609 1 7 HELIX 30 30 PHE B 612 VAL B 624 1 13 HELIX 31 31 THR B 625 SER B 637 1 13 HELIX 32 32 HIS B 639 LEU B 645 1 7 HELIX 33 33 HIS B 648 ILE B 660 1 13 HELIX 34 34 THR B 662 ARG B 674 1 13 HELIX 35 35 TYR B 676 LYS B 682 1 7 HELIX 36 36 GLY B 686 LEU B 697 1 12 HELIX 37 37 LYS B 698 SER B 712 1 15 HELIX 38 38 SER B 712 THR B 718 1 7 HELIX 39 39 HIS B 721 GLY B 733 1 13 HELIX 40 40 THR B 734 ALA B 747 1 14 HELIX 41 41 LEU B 748 LEU B 754 1 7 HELIX 42 42 PHE B 757 ASN B 773 1 17 HELIX 43 43 ASP B 776 LYS B 786 1 11 HELIX 44 44 ARG B 788 ILE B 794 1 7 HELIX 45 45 PHE B 797 LYS B 807 1 11 HELIX 46 46 THR B 808 ASP B 834 1 27 HELIX 47 47 TYR B 836 ASN B 852 1 17 HELIX 48 48 ASN B 852 LEU B 867 1 16 HELIX 49 49 GLY B 869 ASN B 873 5 5 HELIX 50 50 THR B 874 GLY B 882 1 9 CISPEP 1 LEU A 588 GLY A 589 0 -11.18 SITE 1 AC1 2 HIS A 719 HIS B 795 SITE 1 AC2 2 THR B 626 GLU B 627 SITE 1 AC3 3 GLN A 679 LYS B 751 ASP B 755 SITE 1 AC4 4 GLN A 851 ASP A 853 ASN B 821 ASN B 822 SITE 1 AC5 4 THR A 735 LYS A 774 THR B 735 LYS B 774 SITE 1 AC6 2 GLN A 851 HIS B 783 SITE 1 AC7 2 THR A 734 THR A 735 CRYST1 65.860 136.180 158.851 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015184 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007343 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006295 0.00000